Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
PARP1 inhib
Welcome,
Profile
Billing
Logout
50 Companies
40 Products
40 Products
346 Diseases
689 Trials
28835 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
54
108
162
216
270
324
378
432
486
540
Lynparza
(olaparib) / Merck (MSD), AstraZeneca
Zejula
(niraparib) / GSK, J&J
AiRuiYi
(fluzoparib) / Jiangsu Hengrui Pharma
Talzenna
(talazoparib) / Pfizer
veliparib
(ABT-888) / AbbVie
Rubraca
(rucaparib) / Pharma& Schweiz
Partruvix
(pamiparib) / BeOne Medicines
iniparib
(BSI 201) / Sanofi
Paishuning
(senaparib) / IMPACT Therap
saruparib
(AZD5305) / AstraZeneca
M9466
/ EMD Serono
Akeega
(abiraterone/niraparib) / J&J
stenoparib
(2X-121) / Allarity Therap, Oncoheroes
NMS-293
/ Nerviano Medical Sciences
SC10914
/ Jiangxi Qingfeng Pharma, Shanghai De Novo Pharmatech
venadaparib
(NOV 1401) / National OncoVenture, Ildong
AZD9574
/ AstraZeneca
nesuparib
(JPI-547) / Jeil
amelparib
(JPI-289) / Jeil, Oncocross
TQB3823
/ Sino Biopharm
TSL1502
/ Tasly
ABT-767
/ AbbVie
AMXI-5001
/ AtlasMedx
CK-102
/ Fortress
HWH340
/ WuXi AppTec, Humanwell Healthcare
RP12146
/ Rhizen
VIO-01
/ Valerio Therap
simmiparib
(SMOCL-9112) / Shanghai Acebright Pharma
